Co-morbidites, CVD and metabolic diseases

ASTHMA_CVDMETABOCOMORB

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
ASTHMA_CVDMETABOCOMORB

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

Summary Statistics

Key figures

All Female Male
Number of individuals 111507 48517 62990
Unadjusted prevalence (%) 36.14 27.96 46.65
Mean age at first event (years) 57.55 56.76 58.16

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 4.66 [4.35, 4.98] <1e-100 20295
15 years 0.01 3.05 [2.83, 3.29] <1e-100 9170
5 years 0.00 4.69 [4.30, 5.11] <1e-100 4272
1 year 0.00 21.15 [18.25, 24.51] <1e-100 3593

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ASTHMA_CVDMETABOCOMORB – Co-morbidites, CVD and metabolic diseases
GWS hits:

Survival analyses between endpoints

Plot

before Co-morbidites, CVD and metabolic diseases
after Co-morbidites, CVD and metabolic diseases

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Co-morbidites, CVD and metabolic diseases